Emerging Paradigms for Antibiotic-Resistant Infections: Beyond the Pill

Part I. The Rise of Antibiotic Resistance.- Chapter 1. CRISPR-Cas Against Antimicrobial Resistant Pathogens.- Chapter 2. Upsurge in antibiotic resistant infections.- Chapter 3. Navigating the Challenges of Antibiotic Resistance: Origins, Mechanisms, and Global Responses.- Chapter 4. The Rise of Antibiotic Resistance "Silent Killer".- Part II. Understanding Non-Antibiotic Advanced Therapies.- Chapter 5. Alternative approaches to counter multi-drug resistant bacterial pathogens.- Chapter 6. A potential strategy to manage antibiotic resistance is to employ anti-quorum sensing techniques.- Chapter 7. Revolutionizing Healthcare: Unleashing the Potential of Immunotherapies to Strengthen the Body's Immune Defense Against Antibiotic-Resistant Pathogen.- Chapter 8. Beyond Antibiotics: Pioneering Strategies in Infection Control to Counter Antibiotic Resistance's Rising Tide.- Chapter 9. Revolutionizing Infection Control: Harnessing the Power of Stem Cells for Precision Antimicrobial Therapy.- Chapter 10. Combatting Antibiotic Resistance: Leveraging Fecal Microbial Transplantation for Gut Health.- Chapter 11. A Journey Beyond Resistance: Discovering The Promise of Non-Antibiotic Therapies.- Chapter 12. The Rise of Antibiotic Resistance: A Global Threat, Origin and Evolution of Antibiotic Resistance: Current Scenario and Future Prospective.- Chapter 13. Functional Nanomaterials in Antimicrobial Therapy for Antibiotic-Resistant Bacterial Infections.- Chapter 14. Association and contribution of dentistry in creating and sharing the burden of antibiotic-resistant microbial world.- Part III. Phage Therapy: Viral Warrior against Bacterial Invaders.- Chapter 15. Bacteriophages: The natural combatants to fight AMR.- Chapter 16. Reviving Phage Therapy: A Novel Approach to Treat Respiratory-associated Infections.- Chapter 17. The Art and Science of Defeating Superbugs: Present and Future of Phage Therapy.- Chapter 18. Phage therapy: Challenges in Its Development and Clinical Implementation.- Chapter 19. Breakthroughs in the Non-Antibiotic Therapies for Infectious Disease Treatment- From Phages to Peptides and Beyond.- Chapter 20. Synergistic effects of phage and antibiotic combinations against pathogenic bacteria.- Chapter 21. Phage Therapy Reimagined: Viral Solutions for Antibiotic Resistant Challenges.- Part IV. Immunotherapies: Boosting the Body's Defense.- Chapter 22. Diverse Properties of Tinospora Cordifolria (Giloy, Heart Leaved Moonseed) world wild use for Immunotherapies; Boosting the body defense and Immune support.- Part V. Natural Antimicrobial Solutions: Nature's Weapon.- Chapter 23. Antimicrobial Efficacy of Rutin: Bridging the gap between Traditional Medicine and Modern Science.- Chapter 24. Beyond Pharmaceuticals: Tapping into Nature's Weapons against Pathogenic Resilience.- Chapter 25. Exploring the potential of phytochemicals: A herbal boon against the MDR Bacteria associated with the chronic wounds.- Chapter 26. Harnessing Nature's Pharmacy: Medicinal Plants Combatting Bacterial Infections in the Aquatic Environment.- Chapter 27. Essential Oil- Natural Weapons to Overcome Antimicrobial Resistance.- Chapter 28. Antimicrobial activity of Plant and Cyanobacterial Secondary Metabolites for Therapeutic Advancements in Modern Medicine.- Chapter 29. Antimicrobial aspects of Brazilian Red Propolis and its compounds.- Chapter 30. Phytochemicals as source of novel antimicrobial agents against the rapidly evolving antimicrobial resistance.- Chapter 31. Natural antimicrobial compounds are an alternative to synthetic antibiotics.- Part VI. Bacteriophage-Derived Enzymes: Enlisting Nature's Allies.- Chapter 32. Phage Power: Harnessing Nature's Arsenal in the Battle Against Microbial Threats for Sustainable Healthcare.- Chapter 33. Bacteriophages derived enzymes as potential alternatives for the treatment of MDR bacterial infections.- Chapter 34. Nature's Allies: Bacteriophage-Derived Enzymes to Combat Resistant Bacteria.- Chapter 35. Advancing Beyond Antibiotics: The Pioneering Use of Bacteriophage Enzymes.- Part VII. Overcoming Challenges and regulatory Hurdles.- Chapter 36. Overcoming Challenges and regulatory Hurdles for Sustainable Bacteriophage therapy products.- Chapter 37. Non-traditional Antibacterial Therapeutic: Focus on Safety, Manufacturing, and Regulatory Dynamics.- Part VIII. Future of Non-Antibiotics Therapies.- Chapter 38.Harnessing Artificial Intelligence and Machine Learning in the Battle Against Antimicrobial Resistant Infections.

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Farmacologia
• Biotecnologia

Biofilm Resistance;Phage Therapy;CRISPR-Cas Systems in Drug Development;Host-Directed Therapies;Nanotechnology in Antibacterial Applications;Antibiotic Stewardship Programs;Genomic Predictors of Drug Resistance